Manjunath P Pai

Summary

Publications

  1. ncbi Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 57:716-22. 2013
  2. ncbi Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults
    Manjunath P Pai
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York 12186, USA
    Pharmacotherapy 32:856-68. 2012
  3. ncbi Clinical pharmacokinetics of oral controlled-release 5-fluorocytosine
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, O Brien 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 54:1237-41. 2010
  4. ncbi Estimating the glomerular filtration rate in obese adult patients for drug dosing
    Manjunath P Pai
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, NY 12208, USA
    Adv Chronic Kidney Dis 17:e53-62. 2010
  5. ncbi Steady-state plasma pharmacokinetics of oral voriconazole in obese adults
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, O Brien 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:2601-5. 2011
  6. ncbi Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients
    Manjunath P Pai
    Albany College of Pharmacy, 106 New Scotland Ave, O Brien Room 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:4006-11. 2011
  7. ncbi Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    Antimicrob Agents Chemother 55:5640-5. 2011
  8. ncbi Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:4277-82. 2011

Collaborators

Detail Information

Publications8

  1. ncbi Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 57:716-22. 2013
    ..This preclinical model has the potential to aid with dose extrapolation for body size and improve assessment of the toxicology potential of antimicrobials in development...
  2. ncbi Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults
    Manjunath P Pai
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York 12186, USA
    Pharmacotherapy 32:856-68. 2012
    ....
  3. ncbi Clinical pharmacokinetics of oral controlled-release 5-fluorocytosine
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, O Brien 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 54:1237-41. 2010
    ..The gastric absorption profile of 5FC-CR was well predicted by in vitro dissolution. Future exploration of a gastroretentive 5FC-CR formulation could overcome the marked lack of bioequivalence observed in the present study...
  4. ncbi Estimating the glomerular filtration rate in obese adult patients for drug dosing
    Manjunath P Pai
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, NY 12208, USA
    Adv Chronic Kidney Dis 17:e53-62. 2010
    ..The role of the alternate body size descriptor, lean body weight to estimate CLcr in obese patients is reviewed...
  5. ncbi Steady-state plasma pharmacokinetics of oral voriconazole in obese adults
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, O Brien 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:2601-5. 2011
    ..96) was identified between C(min) values and AUC(0-τ) values. Adjustment of voriconazole doses in individuals with class II obesity or greater does not appear to be necessary on the basis of body weight...
  6. ncbi Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients
    Manjunath P Pai
    Albany College of Pharmacy, 106 New Scotland Ave, O Brien Room 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:4006-11. 2011
    ..45 liter/kg. Aminoglycoside dosing can be simplified across all weight strata with the use of lean body weight. The CKD-EPI equation best predicts aminoglycoside clearance...
  7. ncbi Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    Antimicrob Agents Chemother 55:5640-5. 2011
    ..Since the systemic exposure of oseltamivir carboxylate is not reduced in class III obese adults with standard doses, a dose increment of oseltamivir is likely to be unnecessary...
  8. ncbi Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:4277-82. 2011
    ....